Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025)
Kazia Therapeutics (KZIA) posted Retained Earnings of $3.4 million for Q4 2025, up 68.83% on a QoQ basis from $2.0 million in Q2 2025, and up 48.84% year-over-year from $2.3 million in Q4 2024.
Kazia Therapeutics (KZIA) has 14 years of Retained Earnings data on file, last reported at $3.4 million in Q4 2025.
- In Q4 2025, Retained Earnings rose 48.84% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (up 48.84% YoY), while the FY2025 annual figure was $2.0 million, down 13.32% from the prior year.
- Retained Earnings improved to $3.4 million in Q4 2025, from $2.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $3.4 million in Q4 2025 and bottomed at -$34.0 million in Q2 2021.
- A 5-year average of -$1.7 million and a median of $2.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings slumped 4971.99% — and 2022, when it soared 105.08%.
- Year by year, Retained Earnings stood at -$34.0 million in 2021, then jumped by 106.64% to $2.3 million in 2022, then gained by 15.63% to $2.6 million in 2023, then decreased by 13.82% to $2.3 million in 2024, then jumped by 48.84% to $3.4 million in 2025.
- The last three Retained Earnings figures came in at $3.4 million (Q4 2025), $2.0 million (Q2 2025), and $2.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.35 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Jun 30, 2021 | -34.04 Mn |
| Dec 31, 2020 | 764,337.76 |
| Jun 30, 2020 | 698,678.39 |
| Dec 31, 2019 | 1.53 Mn |
| Jun 30, 2019 | 1.43 Mn |
| Dec 31, 2018 | 1.41 Mn |
| Jun 30, 2018 | -11.08 Mn |
| Jun 30, 2017 | 1.45 Mn |
| Dec 31, 2016 | 1.53 Mn |
| Jun 30, 2016 | 1.44 Mn |
| Jun 30, 2012 | -280,928.37 |
| Dec 31, 2011 | -122.81 Mn |
| Jun 30, 2011 | -732,561.79 |
| Dec 31, 2010 | -120.16 Mn |
| Jun 30, 2010 | -953,875.16 |
| Dec 31, 2009 | -106.36 Mn |
| Jun 30, 2009 | 4.68 Mn |